Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-27T05:38:37.960Z Has data issue: false hasContentIssue false
  • English
  • Français

High prevalence PF metabolic syndrome in schizophrenic patients: A review of the literature

Published online by Cambridge University Press:  16 April 2020

T. Sanchez-Araña Moreno ,
J.L. Hernandez Fleta ,
M.E. Terres Ruiz ,
J.M. Brito Jinorio ,
A. Salesansky Davidovsky ,
A. Dominguez Santana  and
E. Zerek Benitez
T. Sanchez-Araña Moreno
Affiliation:
Servicio Canario de Salud, Unidad de Salud Mental de Canalejas, Las Palmas de Gran Canaria, Spain
J.L. Hernandez Fleta
Affiliation:
Servicio Canario de Salud, Unidad de Salud Mental de Canalejas, Las Palmas de Gran Canaria, Spain
M.E. Terres Ruiz
Affiliation:
Servicio Canario de Salud, Unidad de Salud Mental de Canalejas, Las Palmas de Gran Canaria, Spain
J.M. Brito Jinorio
Affiliation:
Servicio Canario de Salud, Unidad de Salud Mental de Canalejas, Las Palmas de Gran Canaria, Spain
A. Salesansky Davidovsky
Affiliation:
Servicio Canario de Salud, Unidad de Salud Mental de Canalejas, Las Palmas de Gran Canaria, Spain
A. Dominguez Santana
Affiliation:
Servicio Canario de Salud, Unidad de Salud Mental de Canalejas, Las Palmas de Gran Canaria, Spain
E. Zerek Benitez
Affiliation:
Servicio Canario de Salud, Unidad de Salud Mental de Canalejas, Las Palmas de Gran Canaria, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Schizophrenic patients have a standardized mortality rate that more than doubles the expected rate for the rest of the population. A substantial percentage of the morbidity and mortality in these patients is due to cardiovascular disease. The metabolic syndrome is highly prevalent among schizophrenics and produces a 2-4-fold increase in coronary risk. The objective of the present poster was to analyze the few reports published on the prevalence of metabolic syndrome in the schizophrenic patients and the associated sociodemographic, anthropometric, clinical and psychopharmacological variables.

Most reports concur on the high prevalence of the metabolic sybdroem in schizophrenic patients and, therefore, the prevention, diagnosis and treatment of its components is essential to reduce cardiovascular risk in these individuals.

Type
Poster Session 1: Schizophrenia and Other Psychosis
Information
European Psychiatry , Volume 22 , Issue S1: 15th AEP Congress - Abstract book - 15th AEP Congress , March 2007 , pp. S139
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.